Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 10331708.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neoral is a new formulation of cyclosporine that permits reliable absorption in patients with external biliary drainage. The authors reviewed 227 liver transplant patients receiving primary treatment with Neoral. Headache occurred in 24 patients (11%), mild tremors in 12 patients, paresthesia in 5 patients, acute confusional state in 4 patients, and seizures in 2 patients. It is apparent that Neoral has profoundly reduced the severity of neurotoxicity in liver transplant recipients.
Medical subject headings
- Cyclosporine
- Liver
- Liver Transplantation
- Nervous System Diseases